A. Christine Argento, MD
Northwestern University
The VeriStrat® blood-based immune profiling test provides a personalized view of each patient’s immune response to their lung cancer and helps inform physicians whether their patient has a more aggressive cancer.
Learn more about:
VeriStrat Good results indicate a disease state that is more likely to respond to standard of care treatment.
Download VeriStrat good report
VeriStrat Poor results indicate a chronic inflammatory disease state. These patients may benefit from an alternative treatment strategy2,6, including:
Learn how some of the industry’s leading experts are using Biodesix Lung Reflex® testing in their practice.
Northwestern University
Froedtert & the Medical College of Wisconsin
Chest Center of the Carolines at FirstHealth of the Carolinas
DOWNLOAD OUR INFORMATIONAL BROCHURE
ORDER BIODESIX LUNG REFLEX TESTING
CONTACT OUR TEAM
A leading data-driven diagnostic solutions company helping answer critical clinical questions faced by physicians, researchers, and biopharmaceutical companies, with a primary focus in lung disease.
CORPORATE HEADQUARTERS
2970 Wilderness Place, Suite 100
Boulder, CO 80301
Phone (866) 432-5930
Fax (866) 432-3338
© Copyright 2020 Biodesix.
All Rights Reserved.